HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Itani, S. I. Articles by Ruderman, N. B. Search for Related Content PubMed PubMed Citation Articles by Itani, S. I. Articles by Ruderman, N. B. Social Bookmarking                What's this?

Glucose Autoregulates Its Uptake in Skeletal Muscle

Involvement of AMP-Activated Protein Kinase

From the Diabetes and Metabolism Unit and Departments of Medicine, Physiology and Biochemistry, Boston University Medical Center, Boston, Massachusetts

Preexposure to a low concentration of glucose upregulates glucose transport into skeletal muscle, whereas exposure to a high concentration of glucose has the opposite effect. This autoregulatory process occurs independently of insulin, and the mechanism by which it operates is incompletely understood. Activation of the energy-sensing enzyme AMP-activated protein kinase (AMPK) has been shown to increase insulin-independent glucose transport into skeletal muscle in response to such stimuli as exercise and hypoxia. In the present study, we examined whether AMPK could also mediate glucose autoregulation. The activity of the 2 isoform of AMPK and 2-deoxyglucose uptake were assessed in incubated rat extensor digitorum longus muscle after preincubation for 4 h in media containing 0, 3, 6, or 25 mmol/l glucose. The principal findings were as follows. First, AMPK activity was highest in muscles incubated with no added glucose, and it decreased as the concentration of glucose was increased. In keeping with these findings, the concentration of malonyl CoA was increased, and acetyl CoA carboxylase phosphorylation at serine 79 was decreased as the medium glucose concentration was raised. Second, decreases in AMPK activity at the higher glucose concentrations correlated closely with decreases in glucose transport (2-deoxyglucose uptake), measured during a subsequent 20-min incubation at 6 mmol/l glucose (r² = 0.93, P < 0.001). Third, the decrease in AMPK activity at the higher glucose concentrations was not associated with changes in whole-tissue concentrations of creatine phosphate or adenine nucleotides; however, it did correlate with increases in the rate of glycolysis, as estimated by lactate release. The results suggest that glucose autoregulates its own transport into skeletal muscle by a mechanism involving AMPK. They also suggest that this autoregulatory mechanism is not paralleled by changes in whole-tissue concentrations of creatine phosphate ATP, or AMP, but they leave open the possibility that alterations in a cytosolic pool of these compounds play a regulatory role.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Pelletier and L. Coderre Ketone bodies alter dinitrophenol-induced glucose uptake through AMPK inhibition and oxidative stress generation in adult cardiomyocytes Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1325 - E1332. [Abstract] [Full Text] [PDF]

				M.-J. Lee, D. Feliers, M. M. Mariappan, K. Sataranatarajan, L. Mahimainathan, N. Musi, M. Foretz, B. Viollet, J. M. Weinberg, G. G. Choudhury, et al. A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy Am J Physiol Renal Physiol, February 1, 2007; 292(2): F617 - F627. [Abstract] [Full Text] [PDF]

				T. Nedachi and M. Kanzaki Regulation of glucose transporters by insulin and extracellular glucose in C2C12 myotubes Am J Physiol Endocrinol Metab, October 1, 2006; 291(4): E817 - E828. [Abstract] [Full Text] [PDF]

				K. Fosgerau, C. Fledelius, K. E Pedersen, J. B Kristensen, J. R Daugaard, M. A Iglesias, E. W Kraegen, and S. M Furler Oral administration of glucose promotes intracellular partitioning of fatty acid toward storage in white but not in red muscle. J. Endocrinol., September 1, 2006; 190(3): 651 - 658. [Abstract] [Full Text] [PDF]

				R. S. Lee-Young, M. J. Palmer, K. C. Linden, K. LePlastrier, B. J. Canny, M. Hargreaves, G. D. Wadley, B. E. Kemp, and G. K. McConell Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E566 - E573. [Abstract] [Full Text] [PDF]

				S. B. Jorgensen, E. A. Richter, and J. F. P. Wojtaszewski Role of AMPK in skeletal muscle metabolic regulation and adaptation in relation to exercise J. Physiol., July 1, 2006; 574(1): 17 - 31. [Abstract] [Full Text] [PDF]

				E. W. Kraegen, A. K. Saha, E. Preston, D. Wilks, A. J. Hoy, G. J. Cooney, and N. B. Ruderman Increased malonyl-CoA and diacylglycerol content and reduced AMPK activity accompany insulin resistance induced by glucose infusion in muscle and liver of rats Am J Physiol Endocrinol Metab, March 1, 2006; 290(3): E471 - E479. [Abstract] [Full Text] [PDF]

				M. M. Assifi, G. Suchankova, S. Constant, M. Prentki, A. K. Saha, and N. B. Ruderman AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E794 - E800. [Abstract] [Full Text] [PDF]

				J. Y. Altarejos, M. Taniguchi, A. S. Clanachan, and G. D. Lopaschuk Myocardial Ischemia Differentially Regulates LKB1 and an Alternate 5'-AMP-activated Protein Kinase Kinase J. Biol. Chem., January 7, 2005; 280(1): 183 - 190. [Abstract] [Full Text] [PDF]

				S. B. Jorgensen, J. N. Nielsen, J. B. Birk, G. S. Olsen, B. Viollet, F. Andreelli, P. Schjerling, S. Vaulont, D. G. Hardie, B. F. Hansen, et al. The {alpha}2-5'AMP-Activated Protein Kinase Is a Site 2 Glycogen Synthase Kinase in Skeletal Muscle and Is Responsive to Glucose Loading Diabetes, December 1, 2004; 53(12): 3074 - 3081. [Abstract] [Full Text] [PDF]

				C. Bouche, S. Serdy, C. R. Kahn, and A. B. Goldfine The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes Endocr. Rev., October 1, 2004; 25(5): 807 - 830. [Abstract] [Full Text] [PDF]

				G.-i. Kusakai, A. Suzuki, T. Ogura, S.'i. Miyamoto, A. Ochiai, M. Kaminishi, and H. Esumi ARK5 Expression in Colorectal Cancer and Its Implications for Tumor Progression Am. J. Pathol., March 1, 2004; 164(3): 987 - 995. [Abstract] [Full Text] [PDF]

				S. B. Jorgensen, B. Viollet, F. Andreelli, C. Frosig, J. B. Birk, P. Schjerling, S. Vaulont, E. A. Richter, and J. F. P. Wojtaszewski Knockout of the {alpha}2 but Not {alpha}1 5'-AMP-activated Protein Kinase Isoform Abolishes 5-Aminoimidazole-4-carboxamide-1-{beta}-4-ribofuranosidebut Not Contraction-induced Glucose Uptake in Skeletal Muscle J. Biol. Chem., January 9, 2004; 279(2): 1070 - 1079. [Abstract] [Full Text] [PDF]

				N. B. Ruderman, A. K. Saha, and E. W. Kraegen Minireview: Malonyl CoA, AMP-Activated Protein Kinase, and Adiposity Endocrinology, December 1, 2003; 144(12): 5166 - 5171. [Abstract] [Full Text] [PDF]